Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study To Evaluate the Sensitivity of Circulating Iset® by Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

NCT06546007 is registered in ClinicalTrials.gov with Rarecells Diagnostics SAS as lead sponsor.

NCT NCT06546007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06546007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study To Evaluate the Sensitivity of Circulating Iset® by Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
Lead sponsor
Rarecells Diagnostics SAS
Phase
Observational
Overall status
Recruiting
Start date
November 13, 2024
Completion date
October 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, pulmonary neoplasm